Neoglycoconjugate of Tetrasaccharide Representing One Repeating Unit of the Streptococcus pneumoniae Type 14 Capsular Polysaccharide Induces the Production of Opsonizing IgG1 Antibodies and Possesses the Highest Protective Activity As Compared to Hexa- and Octasaccharide Conjugates

The use of biotinylated oligosaccharides related to fragments of capsular polysaccharides from Streptococcus pneumoniae serotypes 3 and 14 as a tool for assessment of the level of vaccine-induced antibody response to neoglycoconjugates

(2016) E. A. Kurbatova et al.   RUSSIAN CHEMICAL BULLETIN

The Effect of a BSA Conjugate of a Synthetic Hexasaccharide Related to the Fragment of Capsular Polysaccharide of Streptococcus pneumoniae Type 14 on the Activation of Innate and Adaptive Immune Responses

(2016) Nelli K. Akhmatova et al.   Frontiers in Immunology

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Invasive Disease and Hospital-Treated Pneumonia Among People Aged ≥65 Years: A Retrospective Case-Control Study

(2015) Maya Leventer-Roberts et al.   CLINICAL INFECTIOUS DISEASES

High-resolution mass spectra of biotinylated, HEG-spacered molecular probes with oligosaccharide fragments of the capsular polysaccharides from Streptococcus pneumoniae

(2015) Alexander O. Chizhov et al.   MENDELEEV COMMUNICATIONS

Organic and hybrid molecular systems

(2015) Valentine P. Ananikov et al.   MENDELEEV COMMUNICATIONS

Development of approaches to a third-generation carbohydrate-conjugate vaccine againstStreptococcus pneumoniae: the search for optimal oligosaccharide ligands

(2015) M L Gening et al.   RUSSIAN CHEMICAL REVIEWS

Synthesis of oligosaccharide fragments of the Streptococcus pneumoniae type 14 capsular polysaccharide and their neoglycoconjugates with bovine serum albumin

(2014) E. V. Sukhova et al.   RUSSIAN CHEMICAL BULLETIN

Development of approaches to creation of experimental test system for evaluation of antigenic activity of synthetic oligosaccharide ligands related to fragments of the Streptococcus pneumoniae type 14 capsular polysaccharide

(2013) E. A. Kurbatova et al.   BIOCHEMISTRY-MOSCOW

Carbohydrates and T cells: A sweet twosome

(2013) Fikri Y. Avci et al.   SEMINARS IN IMMUNOLOGY

Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: A review

(2012) E. Jauneikaite et al.   VACCINE

Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults

(2011) Daniel M. Musher et al.   Human vaccines & immunotherapeutics

Synthetic  -(1->6)-Linked N-Acetylated and Nonacetylated Oligoglucosamines Used To Produce Conjugate Vaccines for Bacterial Pathogens

(2009) M. L. Gening et al.   INFECTION AND IMMUNITY

Identification of the Smallest Structure Capable of Evoking Opsonophagocytic Antibodies against Streptococcus pneumoniae Type 14

(2008) D. Safari et al.   INFECTION AND IMMUNITY